Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | GUFICBIO Gufic Biosciences Limited Pharma · Small | BLISSGVS Bliss GVS Pharma Limited Pharma · Small | NOVARTIND Novartis India Limited Pharma · Small | INNOVACAP Innova Captab Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 27 | 45 | 45 | 48 |
| Verdict | OVERVALUED | WATCHLIST | WATCHLIST | FAIR VALUE |
| Style | OVERVALUED | Financial Turnaround | Financial Turnaround | Financial Turnaround |
| Piotroski | 8/9 | 8/9 | 7/9 | 8/9 |
| Valuation | 0/30 | 6/30 | 5/30 | 5/30 |
| Growth | 12/25 | 13/25 | 15/25 | 17/25 |
| Quality | 0/20 | 4/20 | 2/20 | 8/20 |
| Balance Sheet | 8/15 | 10/15 | 13/15 | 9/15 |
| Cash Flow | 2/10 | 8/10 | 5/10 | 4/10 |
| Price | ₹384.5 | ₹421.6 | ₹1,331.4 | ₹914.7 |
| P/E | 58.80 | 34.00 | 36.90 | 35.70 |
| P/B | 5.69 | 3.72 | 4.20 | 4.55 |
| ROE | 10.10% | 11.60% | 11.60% | 13.70% |
| ROCE | 12.30% | 16.80% | 16.20% | 15.00% |
| Debt / Equity | 0.61 | 0.02 | 0.00 | 0.32 |
| FCF Yield | 0.37% | 2.28% | 1.89% | 0.20% |
| Dividend Y | 0.03% | 0.12% | 1.80% | 0.23% |
| Altman Z | 5.28 | 8.38 | 8.13 | 6.36 |
| Promoter % | 72.50% | 35.36% | 70.68% | 50.90% |
| Mkt Cap (₹Cr) | 3778.00 | 4439.00 | 3435.00 | 5009.00 |
| Graham # | ₹97.71 | ₹176.19 | ₹530.16 | ₹325.34 |
| Fair PE | 42.0 | 42.0 | 42.0 | 42.0 |
| MoS % | -43.0% | +17.8% | +16.0% | +11.6% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startGUFICBIO80
BLISSGVS339
NOVARTIND138
INNOVACAP96